Surgical Innovations Group (SUN.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold SUN.L in your mock portfolio yet.
The negative PE ratio and effectively zero EPS indicate that Surgical Innovations Group is not currently generating meaningful positive earnings. This points to weak profitability and limited near-term earnings visibility. Without evidence of improving margins or revenue growth, the financial profile appears challenged.
The stock trades below its 200-day moving average and has fallen 15% over the last month, signaling a weak technical setup. This underperformance versus its longer-term trend suggests ongoing selling pressure and fragile investor sentiment. Without a clear reversal pattern or evidence of support, the near-term technical outlook is negative.
Alternative data for Surgical Innovations Group is mixed but generally subdued rather than strongly positive or negative. The lack of job openings suggests limited current expansion, while social media followership is modest and slightly declining on Twitter/X. LinkedIn presence is relatively stronger, but there are no clear signs of accelerating business momentum from these signals alone.
Overall, the combination of negative earnings metrics, a declining share price below its 200-day moving average, and muted alternative data signals paints a bearish picture for Surgical Innovations Group at present. While the company maintains some professional visibility, there is little in the current data to suggest an imminent turnaround in fundamentals or sentiment. Investors may require clear evidence of improved profitability or growth catalysts before the outlook shifts meaningfully.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started